Simon Goldman
Investment Director, UCL Technology Fund @ Albion Capital Group
Cambridge, United Kingdom
Simon Goldman is a seed investor at Albion Capital Group in Cambridge focused on Biotechnology and Pharmaceutical. Simon Goldman is the Investment Director, of UCL Technology Fund at Albion Capital Group LLP. Simon Goldman attended the University of Cambridge.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Simon Goldman invests in
Stages Simon Goldman invests in
Countries Simon Goldman invests in
Investment Focus
Industry
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Venture - Series Unknown 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
EpilepsyGTx
|
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE). | $10M / Seed / Jun 24, 2024 | |
AstronauTx
|
AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes. | $1.2M / Venture - Series Unknown / Mar 24, 2020 |
Co-Investors
About Albion Capital Group
Albion typically invests £2-5m for a minority stake Series A and early Series B. They support outstanding entrepreneurs who have demonstrated product-market fit, a clear go to market strategy and long term differentiation in a growth market.They look at most sectors, with a particular focus on digital B2B companies – enterprise software andtechnology services – across a broad range of sectors, including digital health, cybersecurity, martech and fintech. Companies that benefit from macro themes around disruption, digital transformation, and the trend towards a data-driven economy are particularly attractive. They also invest in companies commercialising IP from University College London via the UCL Technology Fund.
Albion Capital Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adam Chirkowski
Investment Director
|
|||
David Grimm
Investment Director
|
|||
|
Simon Goldman
Investment Director, UCL Technology Fund
|
|||
Andrew Elder
Partner
|
|||
Andrew Impey
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Simon Goldman invest in?
Simon Goldman invests primarily in Biotechnology and Pharmaceutical startups, most often at Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Simon Goldman last invest?
The most recent investment recorded for Simon Goldman closed in Jun 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
